PRESS RELEASES

Archives

October 31, 2013 - First Patient Enrolled in Phase III Studies Using OptiNose’s Novel Breath Powered™ Device to Deliver Fluticasone Intranasally for Treatment of Nasal Polyps

September 20, 2013 - OptiNose Partner Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal “Headache”

July 2, 2013 - Avanir Pharmaceuticals and OptiNose Announce Development and Commercialization Agreement for a New Fast-Acting Sumatriptan Investigational Product for the Treatment of Acute Migraine

June 28, 2013 - OptiNose to Present Data Highlighting New Migraine Treatment at International Headache Congress